TREATMENTS &
RESEARCH

Search the
latest
treatment
information
here.

Dr. Huntley's
Diagnosis
Checklist

Have a symptom?
See what questions
a doctor would ask.

Diseases » Pheochromocytoma » Clinical Trials

Clinical Trials for Pheochromocytoma

Clinical trials are research studies conducted in an effort to improve overall patient health and care. Each trial involves running supervised tests to determine the effectiveness and safety of new drugs, procedures and/or devices with the aim of answering scientific questions about a disease or condition. Risks and side-effects are also evaluated during these trials with results ranging from being unpleasant, with side effects such as headaches, to more serious or even life-threatening risks. A clinical trial may be separated into phases, or steps, with each step designed to answer a separate research question. This maybe reflected in the trial name.

A brief description of each phase:

Phase I: Usually designed to evaluate safety, determine a safe dosage range, and identify side effects on a small group of patients.
Phase II: If Phase I is successful, the trial is then repeated with a larger group to further evaluate its effect and safety.
Phase III: Trials are conducted on an ever larger group and are compared with the best current treatment while gathering more information on effect and safety.
Phase IV: These studies monitor long-term side effects after the treatment has been marketed.

Clinical Trials data for Pheochromocytoma is grouped into the following categories:-

View by trial name

View by drugs used in Pheochromocytoma clinical trials

Clinical Trials by trial name

The format for each of the following is:

The name of the trial,
followed by whether the trial is recruiting patients,
- The trial may not have started and not yet recruiting, or the trial may have started and do not need any more recruitements, or the trial may be completed.
- Note**: Please follow the link to determine the current trial status.
followed by a list of drug/s, if any, used in the trial

ClinicalTrials.gov has listed the following trials for Pheochromocytoma:

Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors - This study is currently recruiting patients (Current: 23 Nov 2006) - yttrium Y 90-DOTA-tyr3-octreotide
Iodine I 131 Metaiodobenzylguanidine and Arsenic Trioxide in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma - This study has been suspended (Current: 23 Nov 2006) - arsenic trioxide,iodine I 131 metaiodobenzylguanidine
Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma - This study is no longer recruiting patients (Current: 23 Nov 2006) - doxorubicin,filgrastim,ifosfamide
Diagnosis and Treatment of Pheochromocytoma - This study has been completed (Current: 23 Nov 2006)
Diagnosis of Pheochromocytoma - This study is currently recruiting patients (Current: 23 Nov 2006) - Fluorodopamine
Meta-Iodobenzylguanidine (123I mIBG) Scintigraphy in Patients Being Evaluated for Phaeochromocytoma or Neuroblastoma - This study is currently recruiting patients (Current: 23 Nov 2006) - 123I-mIBG (meta-iodobenzylguanidine)
Blood Sampling for Neurochemical and Genetic Testing - This study has been completed (Current: 23 Nov 2006)
131MIBG to Treat Malignant Pheochromocytoma - This study is currently recruiting patients (Current: 23 Nov 2006) - [131]I-MIBG,6-[18F]Fluorodopamine,[123]I-MIBG
Hereditary Paraganglioma: Evaluation of Screening Methods to Detect Tumors in SDH Positive Carriers - This study is currently recruiting patients (Current: 23 Nov 2006)
ULTRATRACE Iobenguane I 131 in Patients With Malignant Pheochromocytoma, Paraganglioma, or Metastatic Carcinoid - This study is currently recruiting patients (Current: 23 Nov 2006) - Ultratrace iobenguane I 131
Penclomedine in Treating Patients With Solid Tumors or Lymphoma - This study has been completed (Current: 23 Nov 2006) - penclomedine
Ecteinascidin 743 in Treating Adults With Advanced Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - ecteinascidin 743
Combination Chemotherapy in Treating Patients With Advanced Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - fluorouracil,leucovorin calcium,topotecan
Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - interferon alfa,interleukin-12
Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - amifostine,carboplatin,cyclophosphamide,sargramostim
Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum - This study has been completed (Current: 23 Nov 2006) - floxuridine,leucovorin calcium,oxaliplatin
Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - indium In 111 pentetreotide
Decitabine in Treating Patients With Melanoma or Other Advanced Cancer - This study has been completed (Current: 23 Nov 2006) - decitabine
Combination Chemotherapy in Treating Patients With Metastatic Solid Tumors - This study has been completed (Current: 23 Nov 2006) - irinotecan,LY231514
Combination Chemotherapy in Treating Patients With Advanced Cancer - This study is no longer recruiting patients (Current: 23 Nov 2006) - fluorouracil,leucovorin calcium,SCH 66336
Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma - This study is no longer recruiting patients (Current: 23 Nov 2006) - doxorubicin,filgrastim,ifosfamide
L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors - This study is no longer recruiting patients (Current: 23 Nov 2006) - L-778,123
Paclitaxel Plus L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphomas - This study is no longer recruiting patients (Current: 23 Nov 2006) - L-778,123,L-778,123/paclitaxel,paclitaxel
Sorafenib and Bevacizumab in Treating Patients With Refractory, Metastatic, or Unresectable Solid Tumors - This study has been suspended (Current: 23 Nov 2006) - bevacizumab,sorafenib tosylate
Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors - This study has been completed (Current: 23 Nov 2006) - cisplatin,doxorubicin,tamoxifen
Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer - This study is currently recruiting patients (Current: 23 Nov 2006) - melphalan
Sodium Stibogluconate and Interferon in Treating Patients With Advanced Solid Tumors, Lymphoma, or Myeloma - This study is currently recruiting patients (Current: 23 Nov 2006) - interferon alfa-2b,sodium stibogluconate

Drugs used in Clinical Trials for Pheochromocytoma

The format for each of the following is:

The drug,
followed by the name of the trial,
followed by whether the trial is recruiting patients,
- The trial may not have started and not yet recruiting, or the trial may have started and do not need any more recruitements, or the trial may be completed.
- Note**: Please follow the link to determine the current trial status.

ClinicalTrials.gov has listed the following drugs in trials for Pheochromocytoma: